New MS drug rituximab shows promise for multiple sclerosis

Genentech Inc. and Biogen Idec Inc.’s cancer drug Rituxan (rituximab) reduced brain lesions in multiple sclerosis patients. – A drug therapy, using rituximab, dramatically reduced the number of inflammatory lesions that form along nerve fibers in brains of multiple sclerosis patients, revealed by researchers recently.

Back pain expenses and disability rising

In US, self-reported back and neck problems accounted for a large proportion of health care expenditures. These spine-related expenditures have increased substantially from 1997 to 2005, without evidence of corresponding improvement in self-assessed health status. – Although expenses related to back and neck problems have increased substantially in the last decade in US, outcomes such as functional disability and work limitations do not appear to be improving, revealed by researchers.

Baxter’s multiple-dose vial Heparin causing allergy

Baxter’s Multiple-dose Vial Heparin Linked to Severe Allergic Reactions. FDA advises health care practitioners to switch suppliers and limit use of drug until problem identified. – The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high “bolus” doses of the drug.

Adverse reactions linked to Botox use, warns FDA

Ongoing safety review of Botox, Botox Cosmetic and Myobloc taking place in US. – The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses.

FDA updates guidance to seafood processors after recent ciguatera poisoning

FDA advises seafood processors about ciguatera fish poisoning in the Northern Gulf of Mexico near the Flower Garden Banks National Marine Sanctuary. – The U.S. Food and Drug Administration (FDA) issued a letter to seafood processors, advising them of recent illnesses linked to consuming fish carrying the ciguatera toxin, which has led to cases of ciguatera fish poisoning (CFP) in consumers.

Pfizer’s anti smoking Chantix latest safety information

Pfizer’s anti smoking Chantix latest safety information

The U.S. Food and Drug Administration (FDA) issued a Public Health Advisory to alert health care providers, patients, and caregivers to new safety warnings concerning Chantix (varenicline), a prescription medication used to help patients stop smoking. – Chantix (varenicline), a prescription medication used to help patients stop smoking reported to have certain adverse effects like changes in behavior, agitation, depressed mood, suicidal ideation, and actual suicidal behavior. US FDA issued a Public Health Advisory to alert health care providers, patients, and caregivers.

Abbott to educate Chicago-area women about heart disease

Abbott named exclusive Chicagoland ‘Hometown’ Partner of the American Heart Association’s ‘Go Red for Women’ Campaign – As a leader in cardiovascular treatment and the exclusive Chicagoland “hometown” partner for the national “Go Red for Women” program, Abbott is partnering with the American Heart Association (AHA) to raise awareness about heart disease, the leading cause of death for women in America.

Study examines effectiveness of antiviral drug to treat mononucleosis

University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. – University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. The goal of the study is to find out if people who take the antiviral drug valomaciclovir recover from mono faster.

European influenza viruses resistant to tamiflu, oseltamivir

Preliminary results from a survey of antiviral drug susceptibility among seasonal influenza viruses circulating in Europe has revealed that some of the A (H1N1) viruses in circulation this winter are resistant to the antiviral drug, oseltamivir (also know by the brand name Tamiflu). – Preliminary surveillance into antiviral drug susceptibility against seasonal flu viruses currently circulating in Europe has revealed that some of the A (H1N1) viruses (13%) have shown resistance to the antiviral drug, oseltamivir (Tamiflu). These viruses however, remain sensitive to the antivirals, zanamivir and amantadine.

Kids food still full of salt, says CASH

Parents are risking the health of their kids by inadvertently feeding them with foods containing high salt content, a new study has found. – Many foods eaten by UK children still contain large amounts of salt, in some cases more than half the daily maximum limit for a 6 year old in a single serving, revealed by researchers. Research carried out with Netmums, a leading parenting website, also shows that many parents are confused about which foods contain salt.

Health Newstrack